FDA’s Revised Electronic Source Data Guidance Less Specific On How Data Should Flow
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA issues its second draft on the topic in two years, going back to the drawing board after comments from industry, but BIO still hasn’t persuaded the agency to explicitly exempt electronic diaries.
You may also be interested in...
Regulatory News In Brief
Minnesota device makers petition FDA. Invacare lays off workers following FDA consent decree. More regulatory news.
Regulatory News In Brief
News on FDA workforce troubles, feedback on CDRH’s eCopy policy and more.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.